A role of matrix metalloproteinase-8 in atherosclerosis

Circulation Research

Volumn 105, Issue 9, 2009, Pages 921-929

  Laxton, Ross C ^a,c   Hu, Yanhua ^b   Duchene, Johan ^a   Zhang, Feng ^a   Zhang, Zhongyi ^b   Leung, Kit Yi ^a   Xiao, Qingzhong ^b   Scotland, Ramona S ^a   Hodgkinson, Conrad P ^a   Smith, Katherine ^c   Willeit, Johann ^d   López Otín, Carlos ^e   Simpson, Iain A ^f   Kiechl, Stefan ^d   Ahluwalia, Amrita ^a   Xu, Qingbo ^b   Ye, Shu ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e UNIVERSIDAD DE OVIEDO   (Spain)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Matrix; Metalloproteinase gene

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; FIBRILLAR COLLAGEN; NEUTROPHIL COLLAGENASE; VASCULAR CELL ADHESION MOLECULE 1; APOLIPOPROTEIN E; COLLAGEN; MMP8 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; GENETIC VARIABILITY; HUMAN; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; AORTA DISEASE; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY DISEASES; COLLAGEN; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTE ROLLING; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 8; MICE; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASCULAR CELL ADHESION MOLECULE-1;

EID: 70350702937     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.200279     Document Type: Article

References (48)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420: 868-874.
2. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8: 221-233. (Pubitemid 46310551)
3. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
4. Lemaitre V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J. ApoE knockout mice expressing human, matrix metalloproteinase-1. in macrophages have less advanced atherosclerosis. J Clin Invest. 2001;107: 1227-1234.
5. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A. Effect of M.MP-2 deficiency on atherosclerotic lesion formation in apoEdeficient mice. Arterioscler Thromb Vase Biol. 2006;26: 1120-1125.
6. Silence J, Lupu F, Collen D, Lijnen HR. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-l (MMP-3) gene inactivation. Arterioscler Thromb Vase Biol. 2001;21: 1440-1445. (Pubitemid 34219805)
7. Johnson JL, George SJ, Newby AC, Jackson CL. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA. 2005;102: 15575-15580.
8. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. Targeted, disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell, migration arterial remodeling and geometrical. Circ Res. 2002;91: 852-859. (Pubitemid 35285084)
9. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation. 2004;109: 1408-1414. (Pubitemid 38387828)
10. Johnson C, Galis ZS. Matrix metalloproteinase-2 and -9 differentially reguelate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vase Biol. 2004;24: 54-60. (Pubitemid 38082411)
11. Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest. 2006;116: 59-69.
12. Liang J, Liu E, Yu Y, Kitajima S, Koike T, Jin Y, Morimoto M, Hatakeyama K, Asada Y, Watanabe T, Sasaguri Y, Watanabe S, Fan J. Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation. 2006;113: 1993-2001.
13. Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM, Whittaker P, Aikawa M. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation. 2005;112: 2708-2715.
14. Schneider F, Sukhova GK, Aikawa M, Canner J, Gerdes N, Tang SM, Shi GP, Apte SS, Libby P. Matrix.-metalloproteinase-14 deficiency in bonemarrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation. 2008;117: 931-939. (Pubitemid 351272591)
15. Herman MP, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M, Schonbeck U. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation. 2001;104: 1899-1904. (Pubitemid 32983231)
16. Turu MM, Krupinski J, Catena E, Roseli A, Montaner J, Rubio F, varez-Sabin J, Cairols M, Badimon L. Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis. 2006;187: 161-169.
17. Tuomainen AM, Nyyssonen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, Sorsa T, Pussinen PJ. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vase Biol. 2007;27: 2722-2728. (Pubitemid 350158928)
18. Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 2006;17: 217-223. (Pubitemid 44038613)
19. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet. 2003;35: 252-257.
20. Foteinos G, Hu Y, Xiao Q, Metzler B, Xu Q. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation. 2008;117: 1856-1863.
21. Ye S, Dunleavey L, Bannister W, Day LB, Tapper W, Collins AR, Day IN, Simpson I. Independent effects of the -21.9 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. Eur J Hum Genet. 2003;11: 437-443. (Pubitemid 36722262)
22. Kiechl S, Willeit J. The natural, course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vase Biol. 1999;19: 1484-1490. (Pubitemid 29263018)
23. Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vase Biol. 1999; 19: 1491-1498.
24. Kiechl S, Lorenz E, Reindl. M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347: 185-192.
25. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol. 2008;52: 378-384.
26. Diekmann O, Tschesche H. Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix, metalloproteinases MMP 8 and MMP 9. Braz J Med Biol Res. 1994;27: 1865-1876.
27. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105: 1605-1612.
28. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system, and cardiovascular risk. Lancet. 2007;369: 1208-1219.
29. Brasier AR, Recinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin, system. Arterioscler Thromb Vase Biol, 2002;22: 1257-1266.
30. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Amai JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion, molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vase Biol. 2000;20: 645-651. (Pubitemid 30151676)
31. Tummala PE, Chen XL, Sundell. CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM. Angiotensin II induces vascular cell, adhesion molecule-1. expression in rat vasculature: a potential, link between the renin-angiotensin system, and atherosclerosis. Circulation, 1999;100: 1223-1229.
32. Zhang L, Cheng J, Ma Y, Thomas W, Zhang J, Du J. Dual, pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IkappaB kinase and ribosomal kinase. Circ Res. 2005;97: 975-982. (Pubitemid 41668910)
33. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, Ley K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84: 1237-1244. (Pubitemid 29270037)
34. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular cell adhesion molecule-1. and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res. 2000;87: 153-159. (Pubitemid 30616912)
35. Cybulsky MI, Uyama K, Li H, Zhu S, Chen. M, Uyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS. A major role for VCAM-I, but not ICAM-I, in early atherosclerosis. J Clin Invest. 2001; 107: 1255-1262. (Pubitemid 32494542)
36. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74: 765-769.
37. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95: 221-227. (Pubitemid 43093236)
38. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2: 161-174. (Pubitemid 37328786)
39. Corvol P, Williams TA, Soubrier F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol. 1995;248: 283-305.
40. Sturrock ED, Natesh R, van Rooyen JM, Acharya KR. Structure of angiotensin I-converting enzyme. Cell Mol Life Sci. 2004;61: 2677-2686.
41. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA. 1988; 85: 9386-9390.
42. Yamamoto D, Takai S, Miyazaki M. Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site. Biochem Biophys Res Commun. 2007;354: 981-984.
43. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molten A, Polverini PJ, Bouck NP. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest. 1996;98: 671-679. (Pubitemid 26349171)
44. Reinhardt D, Sigusch HH, Hensse J, Tyagi SC, Korfer R, Figulla HR. Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart. 2002;88: 525-530. (Pubitemid 35221972)
45. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, Miwa T, Masuyama T. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-Converting enzyme inhibitor. Circulation. 2004;109: 2143-2149.
46. Brower GL, Levick SP, Janicki JS. Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. Am J Physiol Heart Circ Physiol. 2007;292: H3057-H3064.
47. Yamamoto D, Takai S, Jin D, Inagaki S, Tanaka K, Miyazaki M. Molecular mechanism of Imidapril for cardiovascular protection via inhibition of MMP-9. J Mol Cell Cardiol. 2007;43: 670-676.
48. Newby AC, Johnson JL. Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability. Circ Res. 2005;97: 958-960.